Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HPV Vaccination Impact on Cervical Cancer Screening Program: FASTER-Tlalpan Study in Mexico

NCT03105856 is registered in ClinicalTrials.gov with Instituto Nacional de Salud Publica, Mexico as lead sponsor.

NCT NCT03105856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03105856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HPV Vaccination Impact on Cervical Cancer Screening Program: FASTER-Tlalpan Study in Mexico
Lead sponsor
Instituto Nacional de Salud Publica, Mexico
Phase
Phase 4
Overall status
Completed
Start date
January 3, 2017
Completion date
December 15, 2018
Enrollment
3,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical intraepithelial neoplasia, hpv-related cervical carcinoma